Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that the
Company has been invited to present at the William Blair and Company’s 29th
Annual Growth Stock Conference on Thursday, June 11 at 9:20 a.m. CDT at
the Four Seasons Hotel, Chicago, IL. Jack Kraeutler, Chief Executive
Officer, and Bill Motto, Executive Chairman of the Board, are scheduled
to present. A question and answer session will follow the Company’s
presentation. The information provided during the session may not have
been previously disclosed.
Meridian invites investors to listen to management’s remarks on the
Company’s website at www.meridianbioscience.com.
The link to the Conference is on our Investor Relations home page. The
archived broadcast will be available for 90 days.
Forward Looking Statements
The Private Securities Litigation Reform
Act of 1995 provides a safe harbor from civil litigation for
forward-looking statements accompanied by meaningful cautionary
statements. Except for historical information, this report contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, which may be identified by words such as
"estimates", "anticipates", "projects", "plans", "seeks", "may", "will",
"expects", "intends", "believes", "should" and similar expressions or
the negative versions thereof and which also may be identified by their
context. Such statements, whether expressed or implied, are based upon
current expectations of the Company and speak only as of the date made.
The Company assumes no obligation to publicly update or revise any
forward-looking statements even if experience or future changes make it
clear that any projected results expressed or implied therein will not
be realized. These statements are subject to various risks,
uncertainties and other factors that could cause actual results to
differ materially, including, without limitation, the following:
Meridian's continued growth depends, in part, on its ability to
introduce into the marketplace enhancements of existing products or new
products that incorporate technological advances, meet customer
requirements and respond to products developed by Meridian's
competition. While Meridian has introduced a number of internally
developed products, there can be no assurance that it will be successful
in the future in introducing such products on a timely basis. Ongoing
consolidations of reference laboratories and formation of multi-hospital
alliances may cause adverse changes to pricing and distribution.
